• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠的功能性肝胆成像:大鼠磁共振成像与钆-153-EOB-DTPA闪烁扫描术的比较

Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.

作者信息

Schmitz S A, Mühler A, Wagner S, Wolf K J

机构信息

Department of Radiology and Nuclear Medicine, Benjamin Franklin University Hospital Steglitz, Free University of Berlin, Germany.

出版信息

Invest Radiol. 1996 Mar;31(3):154-60. doi: 10.1097/00004424-199603000-00006.

DOI:10.1097/00004424-199603000-00006
PMID:8675423
Abstract

RATIONALE AND OBJECTIVES

Gadolinium-EOB-DTPA (Gd-EOB-DTPA) is a hepatobiliary magnetic resonance (MR) imaging contrast medium designed to detect focal liver lesions. The objective of this study was to evaluate dynamic Gd-EOB-DTPA-enhanced MR imaging as a new method for assessing liver excretory function and to compare it with a scintigraphic method, the gold standard.

METHODS

Changes in scintigraphic liver activity or MR liver signal intensity were intraindividually monitored over time after intravenous injection of 50 mumol Gd/kg of Gd-EOB-DTPA in controls and rats with common bile duct obstruction or L-ethionine-induced fatty liver (n = 6).

RESULTS

A comparison of liver scintigraphy and MR imaging revealed that elimination half-lives of Gd-EOB-DTPA were significantly longer in rats with common bile duct obstruction (scintigraphy: 100 +/- 27 minutes; MR imaging: 59 +/- 18 minutes) or fatty liver (scintigraphy: 94 +/- 30 minutes; MR imaging: 72 +/- 32 minutes) than in controls (scintigraphy: 20 +/- 2 minutes; MR imaging: 18 +/- 3) (P < 0.05).

CONCLUSIONS

Like liver scintigraphy, functional MR liver imaging using Gd-EOB-DTPA is feasible and can differentiate normal controls from models of biliary and hepatocyte disease.

摘要

原理与目的

钆塞酸二钠(Gd-EOB-DTPA)是一种用于检测肝脏局灶性病变的肝胆磁共振(MR)成像造影剂。本研究的目的是评估动态Gd-EOB-DTPA增强MR成像作为评估肝脏排泄功能的新方法,并将其与作为金标准的闪烁扫描法进行比较。

方法

在对照组以及胆总管梗阻或L-乙硫氨酸诱导的脂肪肝大鼠(n = 6)静脉注射50 μmol Gd/kg的Gd-EOB-DTPA后,随时间对个体内闪烁扫描肝脏活性或MR肝脏信号强度的变化进行监测。

结果

肝脏闪烁扫描与MR成像的比较显示,胆总管梗阻大鼠(闪烁扫描:100±27分钟;MR成像:59±18分钟)或脂肪肝大鼠(闪烁扫描:94±30分钟;MR成像:72±32分钟)中Gd-EOB-DTPA的消除半衰期显著长于对照组(闪烁扫描:20±2分钟;MR成像:18±3分钟)(P < 0.05)。

结论

与肝脏闪烁扫描一样,使用Gd-EOB-DTPA的功能性MR肝脏成像可行,并且可以区分正常对照组与胆道和肝细胞疾病模型。

相似文献

1
Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.钆塞酸二钠的功能性肝胆成像:大鼠磁共振成像与钆-153-EOB-DTPA闪烁扫描术的比较
Invest Radiol. 1996 Mar;31(3):154-60. doi: 10.1097/00004424-199603000-00006.
2
Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.钆-乙氧基苄基-二乙三胺五乙酸,一种新型肝脏特异性磁共振造影剂。正常及胆汁淤积大鼠的动力学和增强模式。
Invest Radiol. 1992 Aug;27(8):612-9.
3
Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.钆塞酸二钠在犬体内的肝脏动力学及磁共振成像
Invest Radiol. 1996 Apr;31(4):211-7. doi: 10.1097/00004424-199604000-00005.
4
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.肝脏肿瘤:钆塞酸二钠与钆喷酸葡胺的磁共振成像比较
Radiology. 1996 Jul;200(1):59-67. doi: 10.1148/radiology.200.1.8657946.
5
MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings.钆塞酸二钠增强磁共振成像对大鼠选择性和完全性胆管梗阻肝脏强化的评估:与血清学、微胆管造影及组织学结果的相关性
Radiology. 1994 Mar;190(3):753-8. doi: 10.1148/radiology.190.3.8115623.
6
Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: comparison with Tc-99m-IDA uptake.大鼠肝细胞癌的钆塞酸二钠增强模式:与锝-99m亚氨基二乙酸摄取的比较。
J Magn Reson Imaging. 1994 May-Jun;4(3):351-4. doi: 10.1002/jmri.1880040321.
7
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.钆塞酸二钠作为肝胆磁共振造影剂的I期临床评估:安全性、药代动力学及磁共振成像
Radiology. 1995 Jun;195(3):785-92. doi: 10.1148/radiology.195.3.7754011.
8
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.健康受试者中使用钆贝葡胺和钆塞酸二钠的对比增强磁共振胆胰管造影
Acta Radiol. 2007 May;48(4):362-8. doi: 10.1080/02841850701196922.
9
Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.肝胆系统磁共振成像中的钆塞酸二钠应用:肝胆系统磁共振成像中的谱。
Abdom Radiol (NY). 2016 Sep;41(9):1825-41. doi: 10.1007/s00261-016-0767-y.
10
Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.钆塞酸二钠与钆喷酸葡胺用于肝脏肿瘤对比增强磁共振成像的比较。
J Magn Reson Imaging. 1993 Jan-Feb;3(1):71-7. doi: 10.1002/jmri.1880030113.

引用本文的文献

1
Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments.磁共振成像和单光子发射计算机断层扫描肝胆显像剂在大鼠肝实质中的浓度和药代动力学参数。
Eur Radiol Exp. 2021 Sep 21;5(1):42. doi: 10.1186/s41747-021-00236-y.
2
Comparison between dynamic gadoxetate-enhanced MRI and Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function.动态钆塞酸增强 MRI 与 Tc-美罗芬酸肝胆闪烁成像 SPECT 定量评估肝功能的比较。
Eur Radiol. 2019 Sep;29(9):5063-5072. doi: 10.1007/s00330-019-06029-7. Epub 2019 Feb 22.
3
T2 Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment?
基于钆塞酸增强磁共振成像的多回波狄克逊序列T2映射用于肝脏脂肪定量:它能否用于肝功能评估?
Korean J Radiol. 2017 Jul-Aug;18(4):682-690. doi: 10.3348/kjr.2017.18.4.682. Epub 2017 May 19.
4
Volume change and liver parenchymal signal intensity in Gd-EOB-DTPA-enhanced magnetic resonance imaging after portal vein embolization prior to hepatectomy.肝切除术前门静脉栓塞后钆塞酸二钠增强磁共振成像中的体积变化及肝实质信号强度
Biomed Res Int. 2014;2014:684754. doi: 10.1155/2014/684754. Epub 2014 Sep 11.
5
Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.评估钆塞酸二钠 DCE-MRI 作为肝胆转运体抑制剂的生物标志物。
NMR Biomed. 2013 Oct;26(10):1258-70. doi: 10.1002/nbm.2946. Epub 2013 Apr 7.
6
Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.钆塞酸二钠增强 MRI 用于评估肝硬化患者的肝功能和肝体积。
Br J Radiol. 2013 Jun;86(1026):20120653. doi: 10.1259/bjr.20120653. Epub 2013 Feb 12.
7
Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma.肝细胞癌患者肝脏实质钆-乙氧基苄基二乙三胺五乙酸增强与肝功能的相关性
Oncol Lett. 2012 May;3(5):990-994. doi: 10.3892/ol.2012.629. Epub 2012 Mar 1.
8
Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.使用 Gd-EOB-DTPA 增强型肝脏 MRI 评估原发性胆汁性肝硬化的肝功能。
HPB (Oxford). 2010 Oct;12(8):567-76. doi: 10.1111/j.1477-2574.2010.00223.x.
9
The effect of the amide substituent on the biodistribution and tolerance of lanthanide(III) DOTA-tetraamide derivatives.酰胺取代基对镧系元素(III)DOTA - 四酰胺衍生物生物分布和耐受性的影响。
Invest Radiol. 2008 Dec;43(12):861-70. doi: 10.1097/RLI.0b013e318186531d.
10
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.用于肝脏对比增强磁共振成像的肝胆对比剂:特性、临床研发与应用
Eur Radiol. 2004 Apr;14(4):559-78. doi: 10.1007/s00330-004-2236-1. Epub 2004 Feb 25.